Abbott Laboratories

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Abbott Laboratories
Ownership
Public
Status
Active
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Illinois
Headquarters city
Abbott Park
Headquarters state / province
Illinois
Headquarters country
United States
Fiscal year end
December
Ticker symbol
ABT
Primary stock exchange
NYSE

Identifiers

SEC CIK
0000001800
EIN
36-0698440

Board of directors

Follow this board

Chief executives

Robert B. Ford · CHAIRMAN AND CEO
Dates unknown

Director election results

Annual meeting of April 24, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

8 of this board's directors also sit on 14 other boards.

Network of Abbott Laboratories's board connections 3M Company 3M Company AbbVie Inc. AbbVie Inc. Accenture plc Accenture plc Adaptive Biotechnologies Corporation Adaptive Biotechnologi... Align Technology Inc. Align Technology Inc. American Exceptionalism Acquisition Corp. A American Exceptionalis... GE Aerospace GE Aerospace General Dynamics Corporation General Dynamics Corpo... Mondelez International Inc. Mondelez International... Northern Trust Corporation Northern Trust Corpora... Parsons Corporation Parsons Corporation Ryerson Holding Corporation Ryerson Holding Corpor... Teledyne Technologies Incorporated Teledyne Technologies... Waystar Holding Corp. Waystar Holding Corp. Darren W. McDew Darren W. McDew John G. Stratton John G. Stratton Kevin T. Conroy Kevin T. Conroy Michael F. Roman Michael F. Roman Michael O'Grady Michael O'Grady Michelle Kumbier Michelle Kumbier Nancy McKinstry Nancy McKinstry Robert J. Alpern Robert J. Alpern Abbott Laboratories
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$4,402,807
6 purchases by 4 insiders
Sold, last 12 months
$47,538,622
11 sales by 7 insiders
Date Insider Transaction Shares Price Value
Sep 23, 2026 Kevin T. Conroy Director Shares withheld for tax −52,507 $103.99 $5,460,203
Sep 2, 2026 MCCOY JOHN A. JR. Officer (VICE PRESIDENT AND CONTROLLER) Open-market sale −27 $109.54 $2,958
Sep 1, 2026 MCCOY JOHN A. JR. Officer (VICE PRESIDENT AND CONTROLLER) Shares withheld for tax −52 $110.36 $5,739
Sep 1, 2026 Boudreau Philip P Officer (EVP AND CFO) Shares withheld for tax −388 $110.36 $42,820
Aug 25, 2026 Robert B. Ford Director, Officer (CHAIRMAN AND CEO) Option exercise +151,869 $44.40 $6,742,984
Aug 25, 2026 Robert B. Ford Director, Officer (CHAIRMAN AND CEO) Option exercise +246,963 $59.94 $14,802,962
Aug 25, 2026 Robert B. Ford Director, Officer (CHAIRMAN AND CEO) Open-market sale −218,535 $115.57 $25,256,090
Aug 25, 2026 Robert B. Ford Director, Officer (CHAIRMAN AND CEO) Open-market sale −180,297 $116.19 $20,948,708
Aug 12, 2026 Morrone Louis H. Officer (EXECUTIVE VICE PRESIDENT) Discretionary transaction −12 $107.99 $1,296
Aug 11, 2026 Morrone Louis H. Officer (EXECUTIVE VICE PRESIDENT) Open-market sale −5,850 $109.83 $642,506
Jun 30, 2026 Morrone Louis H. Officer (EXECUTIVE VICE PRESIDENT) Shares withheld for tax −269 $92.71 $24,939
Jun 27, 2026 Cushman Elizabeth C. Officer (EVP, GC AND SECRETARY) Shares withheld for tax −560 $94.12 $52,707
May 7, 2026 John G. Stratton Director Open-market purchase +2,000 $86.82 $173,640
Apr 28, 2026 Moreland Mary K Officer (EXECUTIVE VICE PRESIDENT) Discretionary transaction +5,314 $94.41 $501,695
Apr 27, 2026 Daniel J. Starks Director Open-market purchase +10,000 $92.65 $926,500

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.